TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Zora Biosciences Oy
Closing information (x1000 EUR)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
216
|
660
|
1,064 |
| Financial expenses |
94
|
41
|
30 |
| Earnings before taxes |
-903
|
-392
|
-424 |
| Total assets |
4,806
|
4,014
|
3,729 |
| Current assets |
134
|
153
|
253 |
| Current liabilities |
502
|
360
|
570 |
| Equity capital |
288
|
260
|
652 |
| - share capital |
60
|
60
|
60 |
| Employees (average) |
14
|
14 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
6.0%
|
6.5%
|
17.5% |
| Turnover per employee |
15
|
47 | |
| Profit as a percentage of turnover |
-418.1%
|
-59.4%
|
-39.8% |
| Return on assets (ROA) |
-16.8%
|
-8.7%
|
-10.6% |
| Current ratio |
26.7%
|
42.5%
|
44.4% |
| Return on equity (ROE) |
-313.5%
|
-150.8%
|
-65.0% |
| Change turnover |
-444
|
-404
|
309 |
| Change turnover % |
-67%
|
-38%
|
41% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.